Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
TEVAPHARMIND SP ADR (NY: TEVA)
24.28 USD  +0.23 (+0.96%)
Official Closing Price  /  Updated: 4:15 PM EDT, Jun 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 7,922,807
Open 24.05
Bid (Size) 24.27 (17700)
Ask (Size) 24.30 (9600)
Prev. Close 24.05
Today's Range 24.05 - 24.78
52wk Range 10.85 - 33.82
Shares Outstanding 1,018,482,488
Dividend Yield 4.90%
Performance
YTD
+27.05%
+27.05%
1 Month
+15.13%
+15.13%
3 Month
+37.33%
+37.33%
6 Month
+35.64%
+35.64%
1 Year
-22.50%
-22.50%
Top News
More News
Teva Scraps A Study In Cluster Headaches — And This Rival Benefits
Alder Biopharmaceuticals gapped up Friday after rival Teva Pharmaceutical scrapped a late-stage study in chronic cluster headaches. Read More
from Investor's Business Daily
Teva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster Headache
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a change in the clinical development program of fremanezumab in chronic cluster headache. The ENFORCE Phase III clinical... Read More
from Business Wire News Releases
More News
Read More
Stock Upgrades: Teva Pharmaceutical Shows Rising Relative Strength
from Investor's Business Daily
Analysis: Positioning to Benefit within Teva Pharmaceutical Industries, Resonant, United Community Financial, Enbridge, Shopify, and Dell Technologies — Research Highlights Growth, Revenue, and Consol
from GlobeNewswire News Releases
IEFA, XITK: Big ETF Inflows
category ETFs
from ETF Channel
Why Alder's CEO Hire Could Indicate It's Seeking A Buyer
from Investor's Business Daily
EFA, QGBR: Big ETF Outflows
category ETFs
from ETF Channel
UPDATE 1-Teva to discontinue study for chronic headache treatment
category companyNews
from Reuters: Company News
Teva discontinues study for chronic headache treatment
category companyNews
from Reuters: Company News
Here's Why Alder Biopharmaceuticals Is Rising Today
category ALDR , TEVA , Market News
from Motley Fool
The Cheapest Drug Stocks to Buy Right Now
category INVA , Market News , TEVA , and 2 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.